PicnicHealth, a California-based company involved in simplifying observational research, announced on Tuesday that it has named Jennifer Stacey as its new chief delivery officer.
In the new role, Stacey will manage the end-to-end delivery of observational studies carried out on the PicnicHealth platform to expedite customer success and drive innovation in the healthcare industry. As chief delivery officer, Stacey will ensure study objectives and timelines are met, streamlining the research experience for life sciences companies and patients.
Stacey has more than 25 years of experience in clinical research and life sciences, delivering results-driven approaches to more than 100 pharmaceutical companies, contract research organisations, and FDA officials. She has worked as vice president of global strategy at Veeva Systems, senior vice president of clinical sciences and operations at TriNetX and in notable positions at inVentiv Health, Citeline, and Cell Signaling Technology.
Galderma's nemolizumab recommended for NHS funding in England and Wales for atopic dermatitis
Merck launches Phase 3 trial for dengue vaccine candidate V181
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
Mezzion Pharma obtains USD20m funding for udenafil Phase 3 clinical development for Fontan patients
UCB announces BIMZELX (bimekizumab-bkzx) three-year data at EULAR 2025
US FDA approves expanded indication for AbbVie's MAVYRET (glecaprevir/pibrentasvir) in acute HCV
MaxCyte and Ori Biotech partner to advance autologous cell therapy manufacturing
OptiBiotix announces publication of positive SlimBiome study in European Journal of Nutrition
Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
Bayer and Broad Institute extend cardiovascular research alliance to advance precision therapies